Recruiting studies: Alpha Radiation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
NA · 11 location(s) · Alpha Tau Medical LTD. · NCT06615635 A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
Phase 1 · 1 location(s) · Alpha Fusion Inc. · NCT07287748 Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)
NA · 2 location(s) · Alpha Tau Medical LTD. · NCT05657743 Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure
Phase N/A · 7 location(s) · Semmelweis University · NCT07016477 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899 Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · 35 location(s) · AstraZeneca · NCT07590934 A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT06202118 Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
NA · 15 location(s) · Alpha Tau Medical LTD. · NCT06698458 Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresect
NA · 3 location(s) · Alpha Tau Medical LTD. · NCT05047094 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT04534127 Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT06202248 MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Phase 1/Phase 2 · 13 location(s) · Perspective Therapeutics · NCT05655312 Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
NA · 1 location(s) · Ain Shams University · NCT07256119 Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Gl
Phase 1/Phase 2 · 13 location(s) · RayzeBio, Inc. · NCT06726161 Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT05632913 Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT05781555 Lead-212 PSV359 Therapy for Patients With Solid Tumors
Phase 1/Phase 2 · 11 location(s) · Perspective Therapeutics · NCT06710756 Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17
Phase 3 · 54 location(s) · RayzeBio, Inc. · NCT05477576 Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 · 8 location(s) · Orano Med Theranostics, SAS · NCT05283330 Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
NA · 12 location(s) · Alpha Tau Medical LTD. · NCT06755359 Low-Count Quantitative SPECT for Men Treated With Radium-223
NA · 1 location(s) · Washington University School of Medicine · NCT07221825 Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
NA · 3 location(s) · Alpha Tau Medical LTD. · NCT06910306 Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
NA · 2 location(s) · Alpha Tau Medical LTD. · NCT04068155 Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for th
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07150715 Alpha Radiation Emitters Device (DaRT) for the Treatment of Liver Metastases
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT05829291 Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Phase 1/Phase 2 · 19 location(s) · Perspective Therapeutics · NCT05636618 Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT06026943

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.